Magnar Bjørås
Magnar Bjørås is a Professor of Clinical and Molecular Medicine at the Norwegian University of Science and Technology (NTNU) and serves as Principal Investigator at the University of Oslo and Oslo University Hospital. He is internationally recognized for his pioneering research in oxidative DNA damage repair, neurodegeneration, and cancer biology. Bjørås drives innovation at the intersection of molecular medicine, diagnostics, and translational research, with a strong track record of leadership at both NTNU and Oslo University Hospital. He is the founder of three biotechnology companies: Lybe Scientific, Zenit Science, and Nocteva. Zenit Science functions as a contract research organization (CRO) specializing in preclinical testing of drug candidates using human patient-derived organoids. Nocteva is dedicated to developing and testing novel therapeutics for rare genetic diseases. Through these ventures, his research group translates fundamental discoveries into impactful clinical applications, reinforcing his commitment to advancing precision medicine.
Abstracts this author is presenting: